GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: A population-based case-control study in North Carolina (United States)

Cancer Causes and Control

Volumn 17, Issue 4, 2006, Pages 385-394

  Huang, Kui ^a   Sandler, Robert S ^b   Millikan, Robert C ^b   Schroeder, Jane C ^b   North, Kari E ^b   Hu, Jennifer ^c  

^a PFIZER INC   (United States)

^b IL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cigarette smoking; Colon cancer; GSTM1; GSTT1; Polymorphisms

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; CLINICAL EXAMINATION; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 33645509470     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-005-0424-1     Document Type: Article

References (69)

1. ACS, Society AC (2003) Cancer Facts and Figures-2003. American Cancer Society, Atlanta
2. ACS, Society AC (2002) Cancer Facts and Figures-2002. American Cancer Society, Atlanta
3. CDC, Prevention CfDCa (2000) Behavior Risk Factor Surveillance System CD-ROM 1999. National Center for Disease Prevention and Health Promotion, Atlanta, GA
4. Barrowman JA, Rahman A, Lindstrom MB, Borgstrom B (1989) Intestinal absorption and metabolism of hydrocarbons. Prog Lipid Res 28(3): 189-203
5. Alexandrov K, Rojas M, Kadlubar FF, Lang NP, Bartsch H (1996) Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. Carcinogenesis 17(9):2081-2083
6. Savela K, Hemminki K (1991) DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. Carcinogenesis 12(3):503-508
7. Rojas M, Alexandrov K, Auburtin G, et al. (1995) Anti-benzo[a]pyrene diolepoxide-DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. Carcinogenesis 16(6):1373-1376
8. Arnould JP, Hermant A, Levi-Valensi P, Belegaud J (1998) Detection of benzo[a]pyrene-DNA adducts from leukocytes from heavy smokers. Pathol Biol (Paris) 46(10):787-790
9. Shinozaki R, Inoue S, Choi KS, Tatsuno T (1999) Association of benzo[a]pyrene-diol-epoxide-deoxyribonucleic acid (BPDE-DNA) adduct level with aging in male smokers and nonsmokers. Arch Environ Health 54(2):79-85
10. Hoffmann D, Hoffmann I, El-Bayoumy K (2001) The less harmful cigarette: a controversial issue, a tribute to Ernst L. Wynder. Chem Res Toxicol 14(7):767-790
11. Bol SA, Horlbeck J, Markovic J, de Boer JG, Turesky RJ, Constable A (2000) Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 21(1):1-6
12. Stuart GR, de Boer JG, Haesevoets R, et al. (2001) Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats. Mutagenesis 16(5):431-437
13. Dingley KH, Curtis KD, Nowell S, Felton JS, Lang NP, Turteltaub KW (1999) DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. Cancer Epidemiol Biomarkers Prev 8(6):507-512
14. Giovannucci E, Martinez ME (1996) Tobacco, colorectal cancer, and adenomas: a review of the evidence. J Natl Cancer Inst 88(23):1717-1730
15. Kahn HA (1966) The Dorn study of smoking and mortality among U.S. veterans: report on eight and one-half years of observation.Natl Cancer Inst Monogr 19:1-125
16. Doll R, Gray R, Hafner B, Peto R (1980) Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 280(6219):967-971
17. Rogot E, Murray JL (1980) Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 95(3):213-222
18. Doll R, Peto R (1977) Mortality among doctors in different occupations. Br Med J 1(6074):1433-1436
19. Sturmer T, Glynn RJ, Lee IM, Christen WG, Hennekens CH (2000) Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst 92(14):1178-1181
20. Wu AH, Paganini-Hill A, Ross RK, Henderson BE (1987) Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 55(6):687-694
21. Heineman EF, Zahm SH, McLaughlin JK, Vaught JB (1994) Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int J Cancer 59(6):728-738
22. Giovannucci E, Colditz GA, Stampfer MJ, et al. (1994) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US women. J Natl Cancer Inst 86(3):192-199
23. Giovannucci E, Rimm EB, Stampfer MJ, et al. (1994) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US men. J Natl Cancer Inst 86(3):183-191
24. Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC (1997) Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 57(21):4787-4794
25. Slattery ML, Potter JD, Friedman GD, Ma KN, Edwards S (1997) Tobacco use and colon cancer. Int J Cancer 70(3):259-264
26. Hsing AW, McLaughlin JK, Chow WH, et al. (1998) Risk factors for colorectal cancer in a prospective study among U.S. white men. Int J Cancer 77(4):549-553
27. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE (2000) Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 92(23):1888-1896
28. Mannervik B, Alin P, Guthenberg C, et al. (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci U S A 82(21):7202-7206
29. Singhal SS, Saxena M, Awasthi S, Ahmad H, Sharma R, Awasthi YC (1992) Gender related differences in the expression and characteristics of glutathione S-transferases of human colon. Biochim Biophys Acta 1171(1):19-26
30. Butkiewicz D, Grzybowska E, Phillips DH, Hemminki K, Chorazy M (2000) Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mol Mutagen 35(2):99-105
31. Cotton SC, Sharp L, Little J, Brockton N (2000) Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151(1):7-32
32. Bolt HM (1994) Genetic and individual differences in the process of biotransformation and their relevance for occupational medicine. Med Lav 85(1):37-48
33. Pemble S, Schroeder KR, Spencer SR, et al. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300(1):271-276
34. Wiencke JK, Pemble S, Ketterer B, Kelsey KT (1995) Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4(3):253-259
35. Ye Z, Parry JM (2003) A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9(10):SR83-SR91
36. Freedman AN, Michalek AM, Marshall JR, et al. (1996) The relationship between smoking exposure and p53 overexpression in colorectal cancer. Br J Cancer 73(8):902-908
37. Slattery ML, Potter JD, Samowitz W, Bigler J, Caan B, Leppert M (1998) NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 7(12):1079-1084
38. Slattery ML, Kampman E, Samowitz W, Caan BJ, Potter JD (2000) Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer 87(5):728-733
39. Slattery ML, Curtin K, Ma K, Schaffer D, Potter J, Samowitz W (2002) GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control 13(6):527-534
40. Tiemersma EW, Kampman E, Bueno de Mesquita HB, et al. (2002) Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control 13(4):383-393
41. Le Marchand L, Hankin JH, Pierce LM, et al. (2002) Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res 506(507):205-214
42. Butler LM, Sinha R, Millikan RC, et al. (2003) Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 157(5):434-445
43. Weinberg CR, Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol 134(4):421-432
44. Wacholder S, Weinberg CR (1994) Flexible maximum likelihood methods for assessing joint effects in case-control studies with complex sampling. Biometrics 50(2):350-357
45. SAS, Institutes. In: 8.2 V, editor. Cary, NC, 2001
46. Darroch J (1997) Biologic synergism and parallelism. Am J Epidemiol 145(7):661-668
47. Rothman KJ, Greenland S (1998) Modern Epidemiology 2. Lippincott-Raven Publishers, Philadelphia
48. Millikan RC, Pittman GS, Newman B, et al. (1998) Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(5):371-378
49. Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K, Hunter DJ (1998) Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study Cancer Epidemiol Biomarkers Prev 7(11):1001-1005
50. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. (1999) Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett 142(1):97-104
51. Chenevix-Trench G, Young J, Coggan M, Board P (1995) Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16(7):1655-1657
52. Deakin M, Elder J, Hendrickse C, et al. (1996) Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 17(4):881-884
53. Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK (1999) Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 8(4-1):289-292
54. Butler WJ, Ryan P, Roberts-Thomson IC (2001) Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 16(6):631-635
55. Saadat I, Saadat M (2001) Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 169(1):21-26
56. Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA (2001) Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 22(7):1053-1060
57. Laso N, Lafuente MJ, Mas S, et al. (2002) Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer. Anticancer Res 22(6):3399-3403
58. Katoh T, Nagata N, Kuroda Y, et al. (1996) Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17(9):1855-1859
59. Sachse C, Smith G, Wilkie MJ, et al. (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23(11):1839-1849
60. Nascimento H, Coy CS, Teori MT, et al. (2003) Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum 46(4):510-515
61. van der Hel OL, Bueno de Mesquita HB, Roest M, et al. (2003) No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12(7):681-682
62. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14(9):1821-1824
63. Kiss I, Sandor J, Pajkos G, Bogner B, Hegedus G, Ember I (2000) Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res 20(1B):519-522
64. Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH (1998) Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1,GSTT1, NAT1 and NAT2. J Toxicol Sci 23(2):140-142
65. Hallier E, Langhof T, Dannappel D, et al. (1993) Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 67(3):173-178
66. Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 463(3):247-283
67. Hayes JD, Pulford DJ (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30(6):445-600
68. Thier R, Pemble SE, Kramer H, Taylor JB, Guengerich FP, Ketterer B (1996) Human glutathione S-transferase T1-1 enhances mutagenicity of 1,2-dibromoethane, dibromomethane and 1,2,3,4-diepoxybutane in Salmonella typhimurium. Carcinogenesis 17(1):163-166
69. BRFSS (2001) North Carolina Behavioral Risk Factor Surveillance System survey. North Carolina Department of Public Health, 2002, Raileigh.